T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$2.03B |
| 2 |
DuPont de Nemours
DD
|
+$1.83B |
| 3 |
Crown Castle
CCI
|
+$1.58B |
| 4 |
Microsoft
MSFT
|
+$1.48B |
| 5 |
TransUnion
TRU
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.72B |
| 2 |
Starbucks
SBUX
|
+$1.59B |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.3B |
| 4 |
Lowe's Companies
LOW
|
+$1.13B |
| 5 |
Philip Morris
PM
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.97% |
| 2 | Financials | 16.84% |
| 3 | Technology | 15.92% |
| 4 | Consumer Discretionary | 13.45% |
| 5 | Industrials | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
CALL
Sysco
SYY
$39.9B
| $5.39M | ﹤0.01% |
+100,000
| New | +$5.2M |
|
1427
Under Armour Class C
UA
$2.24B
| $5.3M | ﹤0.01% |
352,729
-352
| -0.1% | -$5.93K |
|
|
MBT
1428
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $5.27M | ﹤0.01% |
505,200
+466,400
| +1,202% | +$4.32M |
|
|
TWTR
1429
DELISTED
Twitter, Inc.
TWTR
| $5.26M | ﹤0.01% |
311,899
+35
| +0% | +$611 |
|
|
NAUH
1430
DELISTED
National American University Holdings, Inc.
NAUH
| $5.26M | ﹤0.01% |
2,456,503
| – | – |
|
|
BMS
1431
DELISTED
Bemis
BMS
| $5.21M | ﹤0.01% |
114,313
-705,191
| -86% | -$31.5M |
|
1432
Ardelyx
ARDX
$1.01B
| $5.11M | ﹤0.01% |
912,401
-101,100
| -10% | -$533K |
|
1433
Under Armour
UAA
$2.29B
| $5.1M | ﹤0.01% |
309,202
-24,241
| -7% | -$445K |
|
|
ACOR
1434
DELISTED
Acorda Therapeutics
ACOR
| $5.09M | ﹤0.01% |
1,794
+283
| +19% | +$746K |
|
1435
Weyco Group
WEYS
$430M
| $4.99M | ﹤0.01% |
175,765
-90,610
| -34% | -$2.52M |
|
1436
Applied Industrial Technologies
AIT
$13.4B
| $4.98M | ﹤0.01% |
75,669
-1,321,684
| -95% | -$76.7M |
|
|
ASRT
1437
DELISTED
Assertio
ASRT
| $4.96M | ﹤0.01% |
14,280
-77
| -0.5% | -$36.3K |
|
1438
Cheniere Energy
LNG
$56B
| $4.93M | ﹤0.01% |
109,515
+31
| +0% | +$1.37K |
|
1439
Autoliv
ALV
$8.95B
| $4.92M | ﹤0.01% |
55,206
+688
| +1% | +$55.9K |
|
1440
Corvus Pharmaceuticals
CRVS
$1.26B
| $4.88M | ﹤0.01% |
305,916
-38,685
| -11% | -$535K |
|
1441
Enanta Pharmaceuticals
ENTA
$384M
| $4.79M | ﹤0.01% |
+102,444
| New | +$4.12M |
|
1442
Box
BOX
$4.54B
| $4.78M | ﹤0.01% |
247,280
-1,367,319
| -85% | -$25.7M |
|
1443
Wolverine World Wide
WWW
$1.7B
| $4.68M | ﹤0.01% |
162,372
-1,600
| -1% | -$43.5K |
|
1444
AXIS Capital
AXS
$7.31B
| $4.63M | ﹤0.01% |
80,877
+13,991
| +21% | +$864K |
|
1445
Innoviva
INVA
$1.51B
| $4.61M | ﹤0.01% |
326,209
+18,570
| +6% | +$246K |
|
|
SRCI
1446
DELISTED
SRC Energy Inc
SRCI
| $4.58M | ﹤0.01% |
473,823
+11,000
| +2% | +$86.8K |
|
1447
Ingredion
INGR
$6.6B
| $4.55M | ﹤0.01% |
37,736
+179
| +0.5% | +$21.8K |
|
1448
Targa Resources
TRGP
$58.7B
| $4.55M | ﹤0.01% |
96,115
+10,113
| +12% | +$460K |
|
|
SYRS
1449
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $4.54M | ﹤0.01% |
+30,866
| New | +$5.8M |
|
1450
iShares MSCI ACWI ex US ETF
ACWX
$12B
| $4.5M | ﹤0.01% |
+93,026
| New | +$4.39M |
|
Similar funds
T. Rowe Price Associates's Q3 2017 Portfolio in Review
As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
- T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
- T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.
Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.